Silverback Therapeutics, Inc.: Stifel Nicolaus Confirms Neutral Recommendation

[ad_1]







Marketzone with MT Newswires 2022

All the news about SILVERBACK THERAPEUTICS, INC.

Analyst Recommendations for SILVERBACK THERAPEUTICS, INC.

2022 turnover –
–
–
2022 net result -76.0M
–
-73.0M
trso. net 2022 206M
–
198M
PER 2022-1.37x
2022 return–
Capitalization 104M
104M
100.0M
VE / CA 2022–
VE / CA 2023–
Number of employees92
Floating96.8%

Chart SILVERBACK THERAPEUTICS, INC.


Hard :

Period:




Silverback Therapeutics, Inc.: Silverback Therapeutics, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis SILVERBACK THERAPEUTICS, INC.

Short termMiddle termLong term
TrendsBearishBearishBearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationKEEP
Number of Analysts4
Last Closing Price$2.96
Average price target$3.43
Deviation / Average Target16.0%

Officers and Directors


[ad_2]

Source link -88